Drug Profile
Dazmegrel
Alternative Names: UK 38485Latest Information Update: 08 Aug 1994
Price :
$50
*
At a glance
- Originator Pfizer
- Class Anti-ischaemics; Antiasthmatics; Antihypertensives; Antiplatelets
- Mechanism of Action Thromboxane synthase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Arrhythmias; Asthma; Ischaemic heart disorders; Thrombosis